Management of high-risk acute pulmonary embolism: an emulated target trial analysis.
Stadlbauer A, Verbelen T, Binzenhöfer L, Goslar T, Supady A, Spieth PM, Noc M, Verstraete A, Hoffmann S, Schomaker M, Höpler J, Kraft M, Tautz E, Hoyer D, Tongers J, Haertel F, El-Essawi A, Salem M, Rangel RH, Hullermann C, Kriz M, Schrage B, Moisés J, Sabate M, Pappalardo F, Crusius L, Mangner N, Adler C, Tichelbäcker T, Skurk C, Jung C, Kufner S, Graf T, Scherer C, Villegas Sierra L, Billig H, Majunke N, Speidl WS, Zilberszac R, Chiscano-Camón L, Uribarri A, Riera J, Roncon-Albuquerque R Jr, Terauda E, Erglis A, Tavazzi G, Zeymer U, Knorr M, Kilo J, Möbius-Winkler S, Schwinger RHG, Frank D, Borst O, Häberle H, De Roeck F, Vrints C, Schmid C, Nickenig G, Hagl C, Massberg S, Schäfer A, Westermann D, Zimmer S, Combes A, Camboni D, Thiele H, Lüsebrink E; High-risk P. E. Investigator Group.
Stadlbauer A, et al.
Intensive Care Med. 2025 Mar;51(3):490-505. doi: 10.1007/s00134-025-07805-4. Epub 2025 Feb 25.
Intensive Care Med. 2025.
PMID: 39998658
Free PMC article.